Conventional insulin therapy is less responsive to alterations in insulin requirements, and despite frequent blood glucose monitoring and regular adjustment of insulin doses, tighter glycaemic control with conventional therapy is associated with increased risk of hypoglycaemia and related adverse medical outcomes.15, 16, 17. The gene discussed is INS; the disease is Hypoglycemia.